Tachyon Therapeutics logo

Tachyon Therapeutics jobs and careers

About Tachyon Therapeutics

Tachyon Therapeutics develops novel, selective compounds to improve the treatment of cancer. The company is currently conducting Phase 1 clinical research in patients with advanced cancer to assess the safety, pharmacokinetics, and anti-tumor effectiveness of TACH101. The programs will be advanced in a timely, innovative, high-quality, andscientifically sound manner.

Founded in 2019 by Mike Clarke.

Founded
2019
Employees
1 to 10
Total funding
$18.7M

Leadership

The top of Tachyon Therapeutics's org chart, with how many people report into each leader.

SBPhoto of Suman Bhattacharya

Suman Bhattacharya

Sr Vp, Data Science & Development Strategy

3 reports

IPPhoto of Isabel Porter

Isabel Porter

Assist Dir, Planning Administration & Logistics

RKPhoto of Rachel Kudgus

Rachel Kudgus

Director Of Clinical Pharmacology

KLPhoto of Kudgus Lokken

Kudgus Lokken

Director Of Clinical Pharmacology

Jobs at Tachyon Therapeutics

No open positions right now. Explore more companies on TheJobsMap.